ICS Theophylline Reagents
by Beckman Instruments, Inc. 510(k)
Active
510(k) K850856
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK850856 | Date29 Mar 1985 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 6 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- KLS
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3880
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
ICS Theophylline Reagents are an enzyme immunoassay device for the quantitative determination of theophylline in human serum or plasma. The device is substantially equivalent to a legally marketed predicate device and is classified under regulation number 862.3880 with product code KLS.
The reagents are supplied by Beckman Instruments, Inc. and were cleared via the traditional 510(k) pathway under K850856 on March 29, 1985. The device is intended for use in clinical toxicology settings and is not described as sterile, single-use, reusable, or MRI safe in the provided data.
Other devices from Beckman Instruments, Inc.
Questions
AI-generated answers, 22 Sep 2026
What is the intended use of ICS Theophylline Reagents?
ICS Theophylline Reagents are intended for the quantitative determination of theophylline in human serum or plasma, used in clinical toxicology settings to monitor therapeutic drug levels.
How are ICS Theophylline Reagents supplied and what is their format?
The reagents are supplied by Beckman Instruments, Inc. as an enzyme immunoassay device, though the provided data does not specify whether they are liquid, lyophilized, kit-based, or single-use.
What regulatory pathway was used for ICS Theophylline Reagents and when was it cleared?
ICS Theophylline Reagents were cleared via the traditional 510(k) pathway under submission K850856, with a decision date of March 29, 1985, and are classified as substantially equivalent to a predicate device.